Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
05/03/2012 | CA2815960A1 Tau imaging probe |
05/03/2012 | CA2815910A1 Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer's disease |
05/03/2012 | CA2815582A1 Treatment of mecp2-associated disorders |
05/03/2012 | CA2815542A1 Use of a spironolactone-based composition that exhibits an inhibitory action on t-lymphocyte activation which is useful for preventing and/or treating multiple sclerosis |
05/03/2012 | CA2815278A1 Immunogenic compositions and methods for treating neurologic disorders |
05/03/2012 | CA2814905A1 Indole derivatives and process for their preparation |
05/03/2012 | CA2808196A1 Peptide compound useful for inhibiting amyloid plaque formation |
05/03/2012 | CA2804797A1 Therapeutic compositions for diabetic symmetrical polyneuropathy and/or tactile allodynia |
05/02/2012 | EP2447265A1 Novel thiophene carboxamide derivative and medicinal use of same |
05/02/2012 | EP2447264A1 N-substituted-cyclic amino derivative |
05/02/2012 | EP2447254A1 Crystals |
05/02/2012 | EP2446883A1 Treatment of inflammation |
05/02/2012 | EP2446881A1 Orally Dissolving Films |
05/02/2012 | EP2446037A2 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene |
05/02/2012 | EP2445899A1 Novel fumarate salts of a histamine h3 receptor antagonist |
05/02/2012 | EP2445887A2 Novel azabicyclohexanes |
05/02/2012 | EP2445877A2 Bicyclic compounds and methods of making and using same |
05/02/2012 | EP2445873A2 Protease inhibitors, compositions and methods of use |
05/02/2012 | EP2445531A2 Methods of increasing neuronal differentiation using antibodies to lysophoshatidic acid |
05/02/2012 | EP2445509A1 Zinc supplementation to increase responsiveness to metalloprotease therapy |
05/02/2012 | EP2445504A1 ENANTIOMERIC COMPOSITIONS OF 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-a]PYRIDIN-3-YL)PROPAN-1-ONE AND RELATED METHODS |
05/02/2012 | EP2445498A1 A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition |
05/02/2012 | EP2445496A2 Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis |
05/02/2012 | EP2445489A2 Compositions for treating drug addiction and improving addiction-related behavior |
05/02/2012 | EP2445488A1 Process for obtaining purified pterostilbene and methods of use thereof |
05/02/2012 | EP2238130B1 Carboxamide compounds and their use as calpain inhibitors |
05/02/2012 | EP2217593B1 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor |
05/02/2012 | EP2039687B1 Therapeutic or prophylactic agent for multiple sclerosis |
05/02/2012 | EP2007724B1 Piperidine derivatives for treatment of alzheimer's disease |
05/02/2012 | EP1934177B1 Prolinamide derivatives as sodium channel modulators |
05/02/2012 | EP1848275B1 Kappa opioid receptor ligands |
05/02/2012 | EP1716851B1 Thioamides and salts thereof and cytokine production inhibitors containing both |
05/02/2012 | EP1693060B1 Therapeutic or preventive agents for ischemic neuropathy |
05/02/2012 | EP1627869B1 Vanilloid receptor modulators |
05/02/2012 | EP1534668B1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
05/02/2012 | EP1517905B1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
05/02/2012 | EP1487431B1 Preventing and/or treating cardiovascular disease and/or associated heart failure |
05/02/2012 | EP1429723B1 Treating effects of excessive reactive oxygen species |
05/02/2012 | EP1389130B1 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
05/02/2012 | EP1372682B1 Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders |
05/02/2012 | EP1032403B1 Nutritional supplement for cerebral metabolic insufficiencies |
05/02/2012 | CN102439136A Mesenchymal stem cells producing inhibitory rna for disease modification |
05/02/2012 | CN102439041A Modulation of the vps 10-domain receptor family for the treatment of mental and behavioural disorders |
05/02/2012 | CN102439015A 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
05/02/2012 | CN102439009A 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
05/02/2012 | CN102439008A 1,2,3-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
05/02/2012 | CN102439007A Amide derivative |
05/02/2012 | CN102439005A Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators |
05/02/2012 | CN102438992A Method of inducing cleavage of amyloid precursor protein to form a novel fragment |
05/02/2012 | CN102438991A Carbinol compound having heterocyclic linker |
05/02/2012 | CN102438988A Resorcinol derivatives as hsp90 inhibitors |
05/02/2012 | CN102438986A Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors |
05/02/2012 | CN102438655A Plant fiber product and method for its manufacture |
05/02/2012 | CN102438622A A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
05/02/2012 | CN102438614A Pyrone analogs for therapeutic treatment |
05/02/2012 | CN102438607A Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain |
05/02/2012 | CN102438587A Compositions for continuous administration of dopa decarboxylase inhibitors |
05/02/2012 | CN102433245A Health-care medicated wine capable of improving memory |
05/02/2012 | CN102432690A Application of Opuntia ficus-indica Milpa Alta polysaccharides to prevention and treatment of chronic neurodegenerative disease |
05/02/2012 | CN102432490A Agomelatine crystal form D and preparation method thereof |
05/02/2012 | CN102432483A Preparation method of acetyl levocarnitine hydrochloride, and drug application of acetyl levocarnitine hydrochloride |
05/02/2012 | CN102430122A Fluoxertine hydrochloride orally disintegrating tablet and preparation method thereof |
05/02/2012 | CN102430117A Modified proteases that inhibit complement activation |
05/02/2012 | CN102430110A CAlprostadil composite medicament of compound fermented cordyceps sinensis powder and alprostadil composite drug |
05/02/2012 | CN102430102A Preparation method for huangqi-guizhi-wuwu granule |
05/02/2012 | CN102430093A Micro-sphere injection capable of resuscitating consciousness and preparation method thereof |
05/02/2012 | CN102430082A Traditional Chinese medicine sachet and preparation method thereof |
05/02/2012 | CN102430070A Traditional Chinese medicament for treating cervical spondylosis |
05/02/2012 | CN102430069A Traditional Chinese medicine for treating delayed epilepsia after cerebral hemorrhage |
05/02/2012 | CN102430060A Cold and hot temperature difference method for processing tall gastrodia tuber |
05/02/2012 | CN102430011A Traditional Chinese medicinal composition for traditional Chinese moxibustion treatment, preparation method and applications thereof |
05/02/2012 | CN102430000A Traditional Chinese medicinal composition for treating Alzheimer-type disease and preparation method thereof |
05/02/2012 | CN102429983A Medicine for treating cold and preparation method thereof |
05/02/2012 | CN102429982A Traditional Chinese medicine granules for treating cold and preparation method thereof |
05/02/2012 | CN102429981A Chinese medicine for treating cold and preparation method thereof |
05/02/2012 | CN102429979A Traditional Chinese medicine composition for treating cold and preparation method thereof |
05/02/2012 | CN102429968A Drug combination for treating insomnia and preparation method thereof |
05/02/2012 | CN102429964A Medicine composition for preventing cognitive disorder of old people after surgical operation |
05/02/2012 | CN102429962A Preparation method of piper laetispicum extractive, extractive and application thereof |
05/02/2012 | CN102429943A Sugar-free erigeron breviscapus mixture and preparation method thereof |
05/02/2012 | CN102429932A Method for extracting lucid ganoderma essence |
05/02/2012 | CN102429931A Compound fermented cordyceps fungus powder salvianic acid combined drug |
05/02/2012 | CN102429930A Compound fermented cordyceps fungus powder and baicalin combined drug, |
05/02/2012 | CN102429929A Compound fermented cordyceps fungus powder and taurine combined drug |
05/02/2012 | CN102429911A Application of ZSTK474 to preparation of medicine for treating autoimmune diseases |
05/02/2012 | CN102429909A Medicine for treating neurodegenerative disease |
05/02/2012 | CN102429908A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
05/02/2012 | CN102429906A Use of nitrogen heterocyclic compound in preparing drug for inhibiting toxicity of amyloid polypeptide |
05/02/2012 | CN102429905A Medicinal composition containing tetrahydropalmatine and imperatorin |
05/02/2012 | CN102429897A Pharmaceutical composition for improving oral bioavailability of morin |
05/02/2012 | CN102429884A Methylphenidate hydrochloride oral cavity disintegrating pharmaceutical composition |
05/02/2012 | CN102429883A Fluoxetine hydrochloride oral cavity disintegrating pharmaceutical composition |
05/02/2012 | CN102429882A Gabapentin prodrug sustained release oral dosage forms |
05/02/2012 | CN102429873A Desmethylvenlafaxine sustained-release pellet and preparation method thereof |
05/02/2012 | CN102145093B Traditional Chinese medicine composition for treating schizophrenia |
05/02/2012 | CN102028910B Chinese medicinal preparation for treating Alzheimer's disease and preparation method thereof |
05/02/2012 | CN101897738B Application of actinidia kolomicta leaf flavonoids in preparing medicines for preventing and treating vascular dementia |
05/02/2012 | CN101856468B Medicinal composition for treating senile dementia and preparation method thereof |
05/02/2012 | CN101785832B Traditional Chinese medicine preparation and preparation method thereof for skin disease treatment |
05/02/2012 | CN101721690B Application of PTD-SOD fusion protein in anti-intoxication alcohol neutralizing product |